Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer
<p dir="ltr">Cisplatin is a widely used platinum‐based chemotherapy agent. Its common adverse effects are neuropathy, nephrotoxicity, electrolyte abnormality, and rarely causing thrombotic vascular toxicity. We present a patient known to have small‐cell lung cancer who developed isch...
محفوظ في:
| المؤلف الرئيسي: | Farah Rashid (13513911) (author) |
|---|---|
| مؤلفون آخرون: | Nabil E. Omar (9545756) (author), Hassan Aaekl (21348284) (author), Ussama Al Homsi (14442150) (author), Alaaeldin Shablak (14778097) (author) |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted
حسب: Reem Ali (9913494)
منشور في: (2022) -
Efficacy of Cannabidiol Combination with Cisplatin or Paclitaxel against Platinum-Resistant Ovarian Cancer Cell Lines
حسب: Ismail, Jana
منشور في: (2022) -
Corneal nerve and endothelial cell damage in patients with transient ischemic attack and minor ischemic stroke
حسب: Hoda Gad (6470522)
منشور في: (2019) -
Determination of Medicago orbicularis Antioxidant, Antihemolytic, and Anti-Cancerous Activities and Its Augmentation of Cisplatin-Induced Cytotoxicity in A549 Lung Cancer Cells
حسب: Abdullah Shaito (20545181)
منشور في: (2024) -
Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
حسب: Iman W. Achkar (4246141)
منشور في: (2018)